Clinical trial
Assessment of Interactions Between IV Methamphetamine and Reserpine
NCT00267657 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Interactions Between IV Methamphetamine and Reserpine
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 31, 2004
- Completion date
- November 30, 2004
- Enrollment
- 30
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.